Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies. 2007

Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
Department of Medicine, New York Medical College, Valhalla, NY10595, USA.

Current evidence suggests that at least part of the cardioprotective benefits of consumption of long-chain n-3 polyunsaturated fatty acids (PUFAs) relates to their incorporation into the phospholipids of cardiac cell membranes. Dietary supplementation with purified extracts of n-3 PUFAs derived from fish oil rapidly alters the composition of fatty acids in blood cell membranes and in other tissues. The present review summarises the time-course and dose-dependent incorporation and washout of n-3 PUFAs in the clinical setting and discusses the implications of these pharmacokinetic data in terms of biological effects.

UI MeSH Term Description Entries
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015525 Fatty Acids, Omega-3 A group of unsaturated fatty acids occurring mainly in fish oils, with three double bonds at particular positions in the hydrocarbon chain. N-3 Fatty Acid,Omega-3 Fatty Acid,Omega-3 Fatty Acids,n-3 Fatty Acids,n-3 Oil,n3 Oil,Omega 3 Fatty Acids,n-3 Oils,n-3 PUFA,n-3 Polyunsaturated Fatty Acid,n3 Fatty Acid,n3 Oils,n3 PUFA,n3 Polyunsaturated Fatty Acid,Acid, N-3 Fatty,Acid, Omega-3 Fatty,Fatty Acid, N-3,Fatty Acid, Omega-3,Fatty Acid, n3,N 3 Fatty Acid,Oil, n-3,Oil, n3,Omega 3 Fatty Acid,PUFA, n-3,PUFA, n3,n 3 Fatty Acids,n 3 Oil,n 3 Oils,n 3 PUFA,n 3 Polyunsaturated Fatty Acid
D019587 Dietary Supplements Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients. Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS. Food Supplements,Neutraceuticals,Dietary Supplementations,Food Supplementations,Herbal Supplements,Nutraceuticals,Nutriceuticals,Dietary Supplement,Food Supplement,Herbal Supplement,Neutraceutical,Nutraceutical,Nutriceutical,Supplement, Food,Supplement, Herbal,Supplementations, Dietary,Supplements, Dietary,Supplements, Food,Supplements, Herbal

Related Publications

Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
January 2012, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
August 1997, The British journal of nutrition,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
July 2009, Prostaglandins, leukotrienes, and essential fatty acids,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
May 1987, The American journal of clinical nutrition,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
May 2012, Current opinion in clinical nutrition and metabolic care,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
January 2014, Frontiers in aging neuroscience,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
September 2011, Nihon rinsho. Japanese journal of clinical medicine,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
July 2016, European journal of clinical nutrition,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
March 1999, Current opinion in clinical nutrition and metabolic care,
Serge Masson, and Roberto Latini, and Mariateresa Tacconi, and Roberto Bernasconi
August 1991, The American journal of clinical nutrition,
Copied contents to your clipboard!